Combined effect of low-power laser irradiation and anthraquinone anticancer drug aclarubicin on survival of immortalized cells: Comparison with mitoxantrone

Cell Biology International

Volumn 30, Issue 8, 2006, Pages 645-652

  Koceva Chyła, Aneta ^a   Wiecławska, Bogusława ^a   Jóźwiak, Zofia ^a   Bryszewska, Maria ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Aclarubicin; Anthracyclines; Cell survival; Laser; Mitoxantrone; MTT assay; Photodynamic therapy (PDT)

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACLARUBICIN; MITOXANTRONE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; IN VITRO STUDY; IRRADIATION; LASER; LOW LEVEL LASER THERAPY; MOUSE; NONHUMAN; PHOTODYNAMICS; PHOTOSENSITIZATION; RED LIGHT; SEMICONDUCTOR;

ACLARUBICIN; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE; CELL SURVIVAL; LASERS; MICE; MITOXANTRONE; MOLECULAR STRUCTURE; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

RODENTIA;

EID: 33746881029     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2006.04.003     Document Type: Article

References (64)

1. Agarwal R., Athar M., Urban S.A., Bickers D.R., and Mukhtar H. Involvement of singlet oxygen in chloroaluminium phtalocyanine tetrasulfonate-mediated photoenhancement of lipid peroxidation in rat epidermal microsomes. Cancer Lett 56 (1991) 125-129
2. Ahram M., Cheong W.-F., Ward K., and Kessel D. Photoproduct formation during irradiation of tissues containing protoporphyrin. J Photochem Photobiol 26 (1994) 203-204
3. Andreoni A., Colasanti A., Kisslinger A., Malatesta V., Mastrocinque M., and Roberti G. Anti-tumor drugs as photochemotherapeutic agents. SPIE (1991) 1525-1535
4. Andreoni A., Colasanti A., Malatesta V., Riccio P., and Roberti G. Enhancement of antitumor drug cytotoxicity via laser photoactivation. Photochem Photobiol 53 (1991) 797-805
5. Andreoni A., Colasanti A., Malatesta V., and Roberti G. Phototoxicity of anthracyclines upon laser excitation in their long-wavelength absorption bands. Radiat Res 127 (1991) 24-29
6. Andreoni A., Colasanti A., and Roberti G. Excited singlet state properties of anthracenedione photosensitizers. J Photochem Photobiol B 14 (1992) 319-328
7. Aufiero B.M., Talwar H., Young C., Krishnan M., Hatfield J.S., Lee H.K., et al. Narrow-band UVB induces apoptosis in human keratinocytes. J Photochem Photobiol B 82 (2006) 132-139
8. Brophy P.F., and Keller S.M. Adriamycin enhanced in vitro and in vivo photodynamic therapy of mesothelioma. J Surg Res 52 (1992) 631-634
9. Canti G., Lattuada D., Morelli S., Nicolin A., Cubeddu R., Taroni P., et al. Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors. Cancer Lett 93 (1998) 255-259
10. Carmichael A.J., and Riesz P. Photoinduced reactions of anthraquinone antitumor agents with peptides and nucleic acid bases: an electron spin resonance and spin trapping study. Arch Biochem Biophys 237 (1985) 433-444
11. Choi Y.H., Ko S.H., Kim S.J., Lee W.Y., Park J.H., and Lee J.M. Induction of cell death by photodynamic therapy with a new synthetic photosensitizer DH-I-180-3 in undifferentiated and differentiated 3T3-L1 cells. Biochem Biophys Res Commun 337 (2005) 1059-1064
12. Consoli U., Van N.T., Neamati N., Mahadevia R., Beran M., Zhao S., et al. Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and negative human myeloid leukemic cell lines. Leukemia 11 (1997) 2066-2074
13. Dereski M.O., Madigan L., and Chopp M. The effect of hyperthermia on photodynamic therapy of normal brain. Neurosurgery 36 (1995) 141-145
14. Dougherty T.J. Photodynamic therapy. Photochem Photobiol 58 (1993) 895-900
15. Fukushima T., Kawai Y., Nakayama T., Yamauchi T., Yoshida A., Urasaki Y., et al. Superior cytotoxic potency of mitoxantrone in interaction with DNA: Comparison with that of daunorubicin. Oncol Res 8 (1996) 95-100
16. Furre I.E., Shahzidi S., Luksiene Z., Moller M.T., Borgen E., Morgan J., et al. Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res 65 (2005) 11051-11060
17. Gao J.P., Lanks K.W., Rosen M., and Lai B.-T. Mechanism of action and spectrum of cell types susceptible to doxorubicin photochemotherapy. Cancer Chemother Pharmacol 40 (1997) 138-142
18. Gomer C.J., Ferrario A., Hayashi N., Rucker N., Szirth B.C., and Murphy A.L. Molecular, cellular, and tissue responses following photodynamic therapy. Lasers Surg Med 8 (1998) 450-463
19. Granville D.J., Levy J.G., and Hunt D.W.C. Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death Differ 4 (1997) 623-628
20. Haghighat S., Castro D.J., Lufkin R.B., Fetterman H.R., Castro D.J., Soudant J., et al. Laser dyes for experimental phototherapy of human cancer: comparison of three rhodamines. Laryngoscope 102 (1992) 81-87
21. Hammer-Wilson M.J., Sun C.H., Ghahramanlou M., and Berns M.W. In vitro and in vivo comparison of argon-pumped and diode lasers for photodynamic therapy using second-generation photosensitizers. Lasers Surg Med 23 (1998) 274-280
22. Hartley J.A., Forrow S.M., Souhami R.L., and Reszka K. Photosensitization of human leukemic cells by anthracenedione antitumor agents. Cancer Res 50 (1990) 1936-1941
23. He J., and Oleinick N.L. Cell death mechanisms vary with photodynamic therapy dose and photosensitizer. Proc SPIE Int Soc Opt Eng 2371 (1995) 92-96
24. He J., Agarval M.L., Larkin H.E., Friedman L.R., Xue L.Y., and Oleinick N.L. The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2. Photochem Photobiol 64 (1996) 845-852
25. He J., Whitacre C.M., Xue L.-Y., Berger N.A., and Olejnick N.L. Protease activation and cleavage of poly (ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment. Cancer Res 58 (1998) 940-946
26. Henderson B., and Dougherty T.J. How does photodynamic therapy work?. Photochem Photobiol 55 (1992) 145-157
27. Heo D.S., Park J.G., Hata K., Day R., Herberman R.B., and Whiteside T.L. Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. Cancer Res 50 (1990) 3681-3690
28. Hu M., Brasseur N., Yildiz S.Z., Van Lier J.E., and Leznoff C.C. Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy. J Med Chem 41 (1998) 1789-1802
29. Jedrzejczak M, 2000. Interactions of anticancer drugs in immortalized cells. Ph.D. Thesis.
30. Jin M.L., Yang B.Q., Zhang W., and Ren P. Combined treatment with photodynamic therapy and chemotherapy for advanced cardiac cancers. J Photochem Photobiol B 12 (1992) 101-106
31. Jin Z., Miyoshi N., Ishiguro K., Umemura S., Kawabata K., Yumita N., et al. Combination effect of photodynamic and sonodynamic therapy on experimental skin squamous cell carcinomas in C3H/HeN mice. J Dermatol 27 (2000) 294-306
32. Kanofsky J.R., and Sima P.D. Preferential cytotoxicity for multidrug-resistant K 562 cells using the combination of a photosensitizer and a cyanine dye. J Photochem Photobiol B 54 (2000) 136-144
33. Karu T., Pyatibrat L., and Kalendo G. Irradiation with He-Ne laser can influence the cytotoxic response of He La cells to ionizing radiation. Int J Radiat Biol 65 (1994) 691-697
34. Kaspers G.J.L., Veerman A.J.P., Pieters R., Van Zantwijk I., Klumper E., Hählen K., et al. In vitro cytotoxicity of mitoxantrone, daunorubicin, and doxorubicin in untreated childhood acute leukaemia. Leukemia 8 (1994) 24-29
35. Kessel D. Photodynamic therapy of neoplastic disease vols. I and II (1990), CRC Press, Boca Raton
36. Kessel D., and Erickson C. Porphyrin photosensitization of multi-drug resistant cell types. Photochem Photobiol 55 (1992) 397-399
37. Koceva-Chyła A., Je{ogonek}drzejczak M., Skierski J., Kania K., and Jóźwiak Z. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: Relation to drug cytotoxicity and caspase-3 activation. Apoptosis 10 (2005) 1497-1514
38. Lanks K.W., Gao J.-P., and Sharma T. Photodynamic enhancement of doxorubicin cytotoxicity. Cancer Chemother Pharmacol 35 (1994) 17-20
39. Lavie G., Kaplinsky C., Toren A., Aizman I., Meruelo D., Mazur Y., et al. A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypercin in leukaemic cells: possible relevance to photodynamic therapy. Br J Cancer 79 (1999) 423-432
40. Li A.S., and Chignell C.F. Spectroscopic studies of cutaneous photosensitizing agents-X. A spin-trapping and direct electron spin resonance study of the photochemical pathway of daunomycin and adriamycin. Photochem Photobiol 45 (1987) 565-570
41. Luo Y., Chang C.K., and Kessel D. Rapid initiation of apoptosis by photodynamic therapy. Photochem Photobiol 63 (1996) 528-534
42. Maier F., Tomaselli F., Gebhard P., Rehak J., Smolle F., and Smolle-Juttner M. Palliation of advanced esophageal carcinoma by photodynamic therapy and irradiation. Ann Thorac Surg 69 (2000) 1006-1009
43. Merlin J.L., Azzi S., Lignon D., Ramacci C., Zeghari N., and Guillemin F. MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy. Eur J Cancer 28 (1992) 1452-1458
44. Moderska M., Maszewski M., Koceva-Chyła A., and Jóźwiak Z. Cytofluorescence localization and cytotoxicity of antitumor drugs doxorubicin and aclarubicin in immortal rodent cells. Folia Histochim Cytobiol 34 Suppl. 2 (1996) 69
45. Moor A.C.E. Signalling pathways in cell death and survival after photodynamic therapy. J Photochem Photobiol B Biol 57 (2000) 1-13
46. Myers C.E., Mimnaugh E., Yeh G., and Sinha B.K. Biochemical mechanisms of tumor cell kill by the anthracyclines. In: Lown J.W. (Ed). Anthracycline and anthracenedione-based anticancer agents (1988), Elsevier, New York 131-162
47. Natale R.B., Cody R.L., Simon M.S., and Wheeler R.H. An in vivo and in vitro trial of aclarubicin in metastatic breast cancer: a novel approach to the study of analogs. Cancer Chemother Pharmacol 31 (1993) 485-488
48. Ohnuma T., Arkin H., and Holland J.F. Effect of cell density on drug-induced cell kill kinetics in vitro (inoculum effect). Br J Cancer 54 (1986) 415-419
49. Oleinick N.L., and Evans H.H. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 150 (1998) S146-S156
50. Paiva M.B., Saxton R.E., Letts G., Chung P.S., Soudant J., Vanderwerf Q., et al. Laser photochemotherapy with anthracyclines on cultured human squamous carcinoma cells. Laryngoscope 106 (1996) 257-262
51. Paiva M.B., Saxton R.E., Graeber I.P., Jongewaard N., Eshraghi A.A., Suh M.J., et al. Improved photochemotherapy of malignant cells with daunomycin and the KTP laser. Lasers Surg Med 23 (1998) 33-39
52. Reszka K., and Lown J.W. Photosensitization of anticancer agents. 8. One- electron reduction of mitoxantrone: an EPR and spectrophotometric study. Photochem Photobiol 50 (1989) 625-633
53. Reszka K., Kolodziejczyk P., Tsoungas P.G., and Lown J.W. Photosensitization by antitumor agents. 6. Production of superoxide radical and hydrogen peroxide during illumination of diaminoanthracenediones in the presence of NADH in aqueous solutions: an EPR study. Photochem Photobiol 47 (1988) 297-304
54. Saxton R.E., Paiva M.B., Lufkin R.B., and Castro D.J. Laser photochemotherapy: a less invasive approach for treatment of cancer. Semin Surg Oncol 11 (1995) 283-289
55. Separovic D., Mann K.J., and Oleinick N.L. Association of ceramide accumulation with photodynamic treatment-induced cell death. Photochem Photobiol 68 (1998) 101-109
56. Serafino A., Sinibaldi-Vallebona P., Pierimarchi P., Bernard P., Gaudiano G., Massa C., et al. Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering?. Anticancer Res 19 (1999) 1909-1918
57. Sitnik T.M., Hampton J.A., and Henderson B.W. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br J Cancer 77 (1998) 1386-1394
58. Skierski J., Koceva-Chyła A., Moderska M., and Jóźwiak Z. Apoptotic changes in immortal rodent cells exposed to anthracycline drugs. Folia Histochim Cytobiol 34 Suppl. 2 (1996) 69
59. Sternberg E.D., and Dolphin D. Second-generation photodynamic agents: a review. J Clin Laser Med Surg 11 (1993) 233-241
60. Sutter E. Quantities and units of optical radiation and their measurement. In: Müller G., and Silney D.H. (Eds). Dosimetry of laser radiation in medicine and biology (1992), SPIE Optical Engineering Press, Washington 38-79
61. 2+ concentrations related to PDT-induced apoptosis in photosensitized human cancer cells. Cancer Lett 128 (1998) 205-210
62. Takemura J., Ohnuma T., and Sekiguchi S. Antitumor efficacy of doxorubicin in combination with cisplatin on human lymphoma cells at various cell densities in vitro. Keio J Med 40 (1991) 72-77
63. van Hillegersberg R., Kort W.J., and Wilson J.H. Current status of photodynamic therapy in oncology. Drugs 48 (1994) 510-527
64. Zaidi S.I.A., Oleinick N.L., Zaim M.T., and Mukhtar H. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic, and biochemical evidence. Photochem Photobiol 58 (1993) 771-776